The company is seeking to turn its business around by adding subscribers to its new clinical business, which prescribes medications such as Ozempic and Zepbound. The company is seeking to turn its business around by adding subscribers to its new clinical business, which prescribes medications such as Ozempic and Zepbound.
​WSJ.com: Markets